Pairwise Plants Revenue and Competitors
Estimated Revenue & Valuation
- Pairwise Plants's estimated annual revenue is currently $49.9M per year.
- Pairwise Plants's estimated revenue per employee is $290,250
- Pairwise Plants's total funding is $115M.
Employee Data
- Pairwise Plants has 172 Employees.
- Pairwise Plants grew their employee count by 9% last year.
Pairwise Plants's People
Name | Title | Email/Phone |
---|---|---|
1 | General Counsel and VP, Operations | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Head Plant Growth Optimization and Production | Reveal Email/Phone |
4 | Head Portfolio Management & Collaborations | Reveal Email/Phone |
5 | Head R&D Operations | Reveal Email/Phone |
6 | VP, Research and Development | Reveal Email/Phone |
7 | VP, Commercial | Reveal Email/Phone |
8 | VP Sales | Reveal Email/Phone |
9 | VP Supply Chain | Reveal Email/Phone |
10 | VP Supply Chain | Reveal Email/Phone |
Pairwise Plants Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.7M | 25 | -7% | N/A | N/A |
#2 | $0.9M | 7 | -78% | N/A | N/A |
#3 | $24.8M | 92 | 7% | N/A | N/A |
#4 | $8.6M | 40 | 8% | N/A | N/A |
#5 | $21.6M | 80 | 10% | N/A | N/A |
#6 | $6.7M | 31 | -11% | N/A | N/A |
#7 | $80.5M | 271 | 20% | N/A | N/A |
#8 | $15.3M | 63 | -3% | N/A | N/A |
#9 | $25.4M | 94 | 6% | N/A | N/A |
#10 | $36.7M | 136 | 2% | N/A | N/A |
What Is Pairwise Plants?
We believe healthy food should be convenient, affordable and sustainable. Pairwise is a new kind of agricultural company focused on using gene editing and leveraging natural diversity in agricultural crops in new ways to address global food challenges. We bring together leaders in agriculture and technology to harness the transformative potential of genome editing to address our food system’s needs. Our team is made up of proven leaders in technology and agriculture, featuring Dr. Tom Adams, our chief executive oficer (CEO), and Dr. Haven Baker, our chief business oficer (CBO), and our team of advisors who are preeminent experts and creators of gene editing technologies: Drs. Feng Zhang, David Liu and J. Keith Joung. We are working to develop new varieties of crops, and to partner with food and agriculture companies who seek to put nutritious food on tables across the globe. From developing novel genome editing tools to leveraging the natural genetic diversity of plants and creating robust partnerships and collaborations, we are working to address the biggest challenges facing the future of food – from affordability to convenience.
keywords:N/A$115M
Total Funding
172
Number of Employees
$49.9M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pairwise Plants News
Pairwise Plants; Tropic Biosciences UK LTD. Yield10 Bioscience, Inc. The appraisal incorporates the business' essential geological regions,...
... its gene editing platform to additional plant-based applications. We are pleased to have Wendy join the Pairwise Executive Team, said...
1 1 Share 4 Mins Read North Carolina-based biotech company, Pairwise recently secured US$90M funding in its Series B round which will boost its gene-editing creation of new fruit and vegetable varieties and break down barriers to increase consumption of fresh produce among American consumers ...
Pairwise has raised a $90 million Series B co-led by Pontifax and Deerfield Management. Based in North Carolina, the company uses gene editing to develop new varieties of fruits and vegetables with traits such as improved taste, better crop yields, increased shelf life and lengthened season avai ...
Agricultural technology startup Pairwise Plants Services Inc. has raised a $90 million Series B funding round to help it build a better berry. Pontifax AgTech Management, a unit of Israeli life sciences firm Pontifax Group, and life sciences investor Deerfield Management led the new funding rou ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 172 | N/A | N/A |
#2 | $15M | 174 | 5% | N/A |
#3 | $24.2M | 176 | -54% | $993.1M |
#4 | $1.2M | 177 | 4% | $692.9M |
#5 | $15M | 177 | 11% | N/A |